Haematology

Showing 8 posts of 38 posts found.

Dr Michael Lutz appointed as new chief executive officer of iotaSciences

August 18, 2023
Business Services Dr Michael Lutz, Haematology, chief executive officer, iotasciences

The pharmaceutical discovery company iotaSciences has announced that it has appointed Dr Michael Lutz as its new chief executive officer. …

Foghorn Therapeutics appoints Alfonso Quintรกs-Cardama as new chief medical officer

August 18, 2023
Business Services Alfonso Quintas-Cardama, Foghorn Therapeutics, Haematology, chief medical officer

The biotechnology company Foghorn Therapeutics has announced the addition of the new chief medical officer, Alfonso Quintรกs-Cardama, who will be …

blood-1813410_960_720

FDA approves BioMarinโ€™s Roctavian for adults with severe haemophilia A

June 30, 2023
Medical Communications BioMarin, FDA, Haematology, Roctavian, haemophilia

Global biotechnology company BioMarin Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has approved Roctavian (valoctocogene roxaparvocec-rvox) …

blood-1813410_960_720

Sanofi shares data about new drug for haemophilia A in paediatric patients

June 26, 2023
Research and Development Haematology, Sanofi, clinical trial, haemophilia a

Sanofi has shared new data from the phase 3 XTEND-Kids study which assessed Altuviiio (Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein) …

acute_lymphoblastic_leukaemia_smear

Astellas Pharma and BMT CTN announce phase 3 data for gilteritinib

June 9, 2023
Research and Development Astellas Pharma, BMT CTN, Haematology, gilteritinib, leukaemia, pharmaceutical

Japanese pharmaceutical company Astellas Pharma and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) have presented their phase …

blood_tests_pic

Innate Pharma announces drug researched with Sanofi receives FDA Fast Track Designation

June 8, 2023
Research and Development Cancer, FDA, Haematology, Innate Pharma, Sanofi, haematology

Innate Pharma has announcedย that the drug jointly researched between itself and Sanofi has received US Food and Drug Administration (FDA) …

Rocket Pharmaceuticals granted FDA RMAT designation for gene therapy

May 24, 2023
Medical Communications FDA, Haematology, RMAT, Rocket Pharmaceuticals, gene therapy

Rocket Pharmaceuticals, a US-based biotechnology company, has announced that it has received US Food and Drug Administration (FDA) Regenerative Medicine …

uniQure announces sale of royalty interest in Hemgenix for up to $400m

May 16, 2023
Sales and Marketing Haematology, Hemgenix, haemophilia, royalties, uniQure

uniQure has announced that it has entered a definitive agreement to sell a portion of the royalty rights due to …

The Gateway to Local Adoption Series

Latest content